Brought to you by 
Neuralstem licenses intraspinal delivery device to Q Therapeutics
28 Apr 2021
Executive Summary
Neural stem cell producer Neuralstem Inc. has licensed Q Therapeutics Inc. (CNS diseases) rights to its spinal cord delivery platform and floating cannula.
Deal Industry
- Biotechnology
- Medical Devices
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Neuralstem licenses intraspinal delivery device to Q Therapeutics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice